SHUYI CAO: Open Payments
NPI 1336724947 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 27 payments from 9 companies in 2025. Trend: 2023 $834 · 2024 $346 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $221 |
| Nalu Medical, Inc. | 4 | $83 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Pacira Pharmaceuticals Incorporated | 2 | $42 |
| Valinor Pharma, LLC | 2 | $37 |
| SPR Therapeutics, Inc | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Averitas Pharma Inc. | 1 | $17 |
| MML US, Inc. | 1 | $7 |
Products named: UBRELVY, Nalu Neurostimulation System, QULIPTA, BOTOX, MOVANTIK, Zilretta, Belbuca, SPRINT PNS System.
Industry payments across TX — which companies pay providers there.
